In conclusion, the miR-512-3p/RPS6KA2 axis plays a critical role in regulating cisplatin sensitivity in ovarian cancer by coordinately influencing both autophagy and ferroptosis signaling pathway at both in vitro and in vivo levels. Here, RPS6KA2 is linked to ovarian carcinoma.